GyrI-like proteins catalyze cyclopropanoid hydrolysis to confer cellular protection
- PMID: 29133784
- PMCID: PMC5684135
- DOI: 10.1038/s41467-017-01508-1
GyrI-like proteins catalyze cyclopropanoid hydrolysis to confer cellular protection
Abstract
GyrI-like proteins are widely distributed in prokaryotes and eukaryotes, and recognized as small-molecule binding proteins. Here, we identify a subfamily of these proteins as cyclopropanoid cyclopropyl hydrolases (CCHs) that can catalyze the hydrolysis of the potent DNA-alkylating agents yatakemycin (YTM) and CC-1065. Co-crystallography and molecular dynamics simulation analyses reveal that these CCHs share a conserved aromatic cage for the hydrolytic activity. Subsequent cytotoxic assays confirm that CCHs are able to protect cells against YTM. Therefore, our findings suggest that the evolutionarily conserved GyrI-like proteins confer cellular protection against diverse xenobiotics via not only binding, but also catalysis.
Conflict of interest statement
The authors declare no competing financial interests.
Figures




Similar articles
-
Fundamental relationships between structure, reactivity, and biological activity for the duocarmycins and CC-1065.J Med Chem. 2009 Oct 8;52(19):5771-80. doi: 10.1021/jm9006214. J Med Chem. 2009. PMID: 19639994 Free PMC article. Review. No abstract available.
-
Catalytic role for arginine 188 in the C-C hydrolase catalytic mechanism for Escherichia coli MhpC and Burkholderia xenovorans LB400 BphD.Biochemistry. 2006 Oct 17;45(41):12470-9. doi: 10.1021/bi061253t. Biochemistry. 2006. PMID: 17029402
-
The bacterial meta-cleavage hydrolase LigY belongs to the amidohydrolase superfamily, not to the α/β-hydrolase superfamily.J Biol Chem. 2017 Nov 3;292(44):18290-18302. doi: 10.1074/jbc.M117.797696. Epub 2017 Sep 20. J Biol Chem. 2017. PMID: 28935670 Free PMC article.
-
Metal cation complexation and activation of reversed CPyI analogues of CC-1065 and duocarmycin SA: partitioning the effects of binding and catalysis.J Am Chem Soc. 2001 Sep 26;123(38):9299-306. doi: 10.1021/ja010769r. J Am Chem Soc. 2001. PMID: 11562212
-
A Short Review on the Synthetic Strategies of Duocarmycin Analogs that are Powerful DNA Alkylating Agents.Anticancer Agents Med Chem. 2015;15(5):616-30. doi: 10.2174/1871520615666141216144116. Anticancer Agents Med Chem. 2015. PMID: 25511515 Review.
Cited by
-
Biosynthesis of DNA-Alkylating Antitumor Natural Products.Molecules. 2022 Sep 27;27(19):6387. doi: 10.3390/molecules27196387. Molecules. 2022. PMID: 36234921 Free PMC article. Review.
-
YgiV promoter mutations cause resistance to cystobactamids and reduced virulence factor expression in Escherichia coli.NPJ Antimicrob Resist. 2024 Nov 5;2(1):33. doi: 10.1038/s44259-024-00050-7. NPJ Antimicrob Resist. 2024. PMID: 39843645 Free PMC article.
-
Newly Discovered Mechanisms of Antibiotic Self-Resistance with Multiple Enzymes Acting at Different Locations and Stages.Antibiotics (Basel). 2022 Dec 26;12(1):35. doi: 10.3390/antibiotics12010035. Antibiotics (Basel). 2022. PMID: 36671236 Free PMC article. Review.
-
Emerging Roles of DNA Glycosylases and the Base Excision Repair Pathway.Trends Biochem Sci. 2019 Sep;44(9):765-781. doi: 10.1016/j.tibs.2019.04.006. Epub 2019 May 9. Trends Biochem Sci. 2019. PMID: 31078398 Free PMC article. Review.
-
TEX264 at the intersection of autophagy and DNA repair.Autophagy. 2022 Jan;18(1):40-49. doi: 10.1080/15548627.2021.1894059. Epub 2021 Mar 17. Autophagy. 2022. PMID: 33726628 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases